Advanced Search
Wang Jiejun, . Induction of apoptosis in human Panereatic cancer cell line SW-1990 by hydroxyl camptothecinum[J]. Cancer Research on Prevention and Treatment, 1998, 25(5): 329-331.
Citation: Wang Jiejun, . Induction of apoptosis in human Panereatic cancer cell line SW-1990 by hydroxyl camptothecinum[J]. Cancer Research on Prevention and Treatment, 1998, 25(5): 329-331.

Induction of apoptosis in human Panereatic cancer cell line SW-1990 by hydroxyl camptothecinum

More Information
  • Objective To study the effect of hydroxyl camptothecinum on human pancreatic cancer cell apoptosis in vitro. Methods :SW-1990 ce-ll line were treated with hydroxyl camptothecinum at different concentrations.cell apoptosis was evaluated by electric microscopy,flow cytom-etry and in situ TUNEL(TdT-mediated dUTP-X nick end labeling). Results The apoptosis rate of Pancreatic cell treatet with hydroxyl cam-ptothecintm at the concentration of 0.05mg/ml for 20 hours is between 13.2%-15.3%,mainly at the early and middle morphological stage.At the concentration of 0.lmg/ml,the rate is between 26.1%-30.4%,mainly at late stage. Conclusion hydroxyl camptothecinum is a potential agent for pancreatic cancer chemotherpy.
  • 1. Barry MA,Behne CA,eastman A.Activation of apoptosis by anti-cancer drugs.Biochem Pharmacol,1990,40:2353-2359.
    2. Burris HA,Rothernberg ML,Kuhn JG,et al.Clinical trails with topoisomerase I inhibitors.Sem O NCOL,1992,19(6):663-669.
    3. 李德玲,王会信,周廷冲.细胞程序性死亡的判定方法.生物化学与生物物理进展,1996,23(23):322-325.
    4. Darzynkiewic Z,Burno S,Bino GD,et al.Features of apoptotic cells measured by flow cytometry.Cytometry,1992,13:795-808.
    5. Majno G,Jotis I.Apoptosis,oncrosis:AN overview of cell death.Am J Path.1995,146(1):3-15
  • Related Articles

    [1]ZHANG Bo, REN Longfei, HU Jinjing, BAI Zhongtian, ZHOU Wence. Effect of LncRNA LINC00857 Knockdown on Migration, Proliferation and Apoptosis of Pancreatic Cancer PANC-1 Cells[J]. Cancer Research on Prevention and Treatment, 2021, 48(2): 127-132. DOI: 10.3971/j.issn.1000-8578.2021.20.0882
    [2]WU Jiang, YUAN Zhi-min, LIN Xiao-hui, YU Hai-qing, ZHANG Lan, PANG Shi-quan. Cisplatin Chronotherapy and Non-chronotherapy Combined with HCPT in Treatment of Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2007, 34(11): 877-880. DOI: 10.3971/j.issn.1000-8578.497
    [4]CHENG Xian-ming, HU Chang-yao, NI Rong-qing, PAN Wei, WANG Hong-min, YU Yi. Clinical Observation of 5-Fu/LV in Combination with Oxaliplatin or HCPT for Gasitric Cancer[J]. Cancer Research on Prevention and Treatment, 2006, 33(09): 679-681. DOI: 10.3971/j.issn.1000-8578.1313
    [7]BAO Le-qun, PENG Yi-mei, YUAN Hong-yin. Clinic Study on the Role of Hydroxycamptothecin and Mateling Postoperative Arterial Infusion in the Prevention of Recurrence after Curative Resection for Human Hepa tocellular carcinoma[J]. Cancer Research on Prevention and Treatment, 2001, 28(04): 303-305. DOI: 10.3971/j.issn.1000-8578.1755
    [8]CHEN Guai-ping, ZAO·Yang, CHAO Hao-ming, et al, . Intravesical Instillation of HCPT to Prevent Recurrence after Surgery for Bladder Cancer[J]. Cancer Research on Prevention and Treatment, 2000, 27(06): 479-480. DOI: 10.3971/j.issn.1000-8578.205
    [9]Yang Sixing, Zhang Xiaobin, Wang Linlong, . Clinical Research of Hydroxycamptothecine Instillation to Prevent Bladder Tumors Recurrence[J]. Cancer Research on Prevention and Treatment, 1999, 26(2): 131-132.

Catalog

    Article views (1627) PDF downloads (231) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return